IPO registrations (S-1, F-1) · Registrants

Cabaletta Bio, Inc.

SEC CIK
1759138 · filings on EDGAR ↗
Registration
Form S-1, first filed 2019-09-30, last 2019-10-16; 1 initial registration, 1 amendment
Outcome
Final prospectus filed 2019-10-25; declared effective 2019-10-24
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
DE
Business address
2929 ARCH STREET, SUITE 600, Philadelphia, PA 19104
Ticker
CABA (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Cabaletta Bio, Inc. on the corporate pages

Offering terms

Proposed price range
$14.00–$16.00 per share (S-1/A filed 2019-10-16)
Final price
$11.00 per share, below the range (424B4 filed 2019-10-25, an initial public offering)
Shares sold
6,800,000
Gross proceeds
$74,800,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol CABA
Lead underwriters
Morgan Stanley; Cowen; Evercore

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
2019-09-30S-1S-1 (registration)Cabaletta Bio, Inc.0001193125-19-258869 ↗
2019-10-16S-1/AS-1/A (amendment)Cabaletta Bio, Inc.0001193125-19-268040 ↗
2019-10-24S-1MEFS-1MEF (added securities)Cabaletta Bio, Inc.0001193125-19-273939 ↗
2019-10-24EFFECTEFFECT (declared effective)Cabaletta Bio, Inc.9999999995-19-002384 ↗
2019-10-25424B4424B4 (final prospectus)Cabaletta Bio, Inc.0001193125-19-274807 ↗
2020-11-18EFFECTEFFECT (declared effective)Cabaletta Bio, Inc.9999999995-20-003226 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2019-10-16S-1/Aregistration statement$14.00–$16.005,800,000-Nasdaq CABA3primary document; range, shares headline, cover names 3document ↗
2019-10-25424B4final prospectus$11.006,800,000$74,800,000Nasdaq CABA3primary document; price sentence, shares headline, proceeds table, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
5AM Partners V, LLCTenPercentOwner62019–2021
5AM Ventures V, L.P.TenPercentOwner62019–2021
Binder GwendolynOfficerEVP, Science & Technology; President, Science & Tech.; See Remarks202019–2026
Bollard CatherineDirector102019–2026
Chang David J.OfficerChief Medical Officer112019–2026
DANIELS BRIANDirector42019–2021
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)TenPercentOwnerOther22019
Deerfield Mgmt IV, L.P.TenPercentOwnerOther22019
Deerfield Mgmt L.P.TenPercentOwnerOther22019
Deerfield Private Design Fund IV, L.P.TenPercentOwnerOther22019
Deerfield Special Situations Fund, L.P.TenPercentOwnerOther22019
Flynn James ETenPercentOwnerOther22019person page Fuzzy
Green JeremyTenPercentOwner22019
HENRIQUES RICHARD C JRDirector82019–2026
Marda AnupOfficerChief Financial Officer112019–2026
Nichtberger StevenDirector,OfficerPresident & CEO172019–2026
PARMAR KUSHTenPercentOwner62019–2021
Redmile Group, LLCTenPercentOwner22019
ROCKLAGE SCOTT MTenPercentOwner62019–2021
Schwab Andrew J.TenPercentOwner62019–2021
Simon MarkDirector112019–2026
Stalter John BrianOfficerGeneral Counsel32019–2021
DEERFIELD PARTNERS, L.P.TenPercentOwnerOther12019
5AM Opportunities I (GP), LLCTenPercentOwner52019–2021
5AM Opportunities I, L.P.TenPercentOwner52019–2021
Brun Scott C.Director82021–2026
Gerard MichaelOfficerGeneral Counsel92021–2026
Das ArunOfficerChief Business Officer72022–2026
Tomasello ShawnDirector72023–2026
Gavel SteveOfficerChief Commercial Officer; CHIEF COMMERCIAL OFFICER32025–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2019-01-14Cabaletta Bio, Inc.BiotechnologyIndefinite$49,999,998161
2018-12-10Cabaletta Bio, Inc.BiotechnologyIndefinite$38,255,593111

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationCabaletta Bio, Inc.PAState business registriesname and state
Business registrationCABALETTA BIO INCPAState business registriesname and state
Plan sponsorCABALETTA BIO INCPAForm 5500 (employee benefit plans)name and state
Form D issuerCabaletta Bio, Inc.PAForm D private offeringsCIK (EXACT)
Lobbying clientCABALETTA BIOPAFederal lobbying (LDA)name and state
SEC filerCabaletta Bio, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerCabaletta Bio, Inc.PATrademarks (USPTO)name and state
Person pageJames E FlynnPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Biological Products, (No Diagnostic Substances) · Health